Article Versions Notes

Ladikou EE, Sharp K, Simoes FA, Jones JR, Burley T, Stott L, Vareli A, Kennedy E, Vause S, Chevassut T, et al. A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance. Cancers. 2025; 17(1):135. https://doi.org/10.3390/cancers17010135

Ladikou, Eleni E., Kim Sharp, Fabio A. Simoes, John R. Jones, Thomas Burley, Lauren Stott, Aimilia Vareli, Emma Kennedy, Sophie Vause, Timothy Chevassut, and et al. 2025. "A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance" Cancers 17, no. 1: 135. https://doi.org/10.3390/cancers17010135

Ladikou, E. E., Sharp, K., Simoes, F. A., Jones, J. R., Burley, T., Stott, L., Vareli, A., Kennedy, E., Vause, S., Chevassut, T., Devi, A., Ashworth, I., Ross, D. M., Hartmann, T. N., Mitchell, S. A., Pepper, C. J., Best, G., & Pepper, A. G. S. (2025). A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance. Cancers, 17(1), 135. https://doi.org/10.3390/cancers17010135